Historical perspectives and emerging trends in fentanyl use: Part 1 – Pharmacological profile
Fentanyl, a potent synthetic opioid, is widely used for severe pain management and anesthesia but poses significant risks due to its extreme potency and addictive potential. It acts primarily on μ-opioid receptors, with additional effects on κ- and δ-receptors, producing analgesia and adverse effect...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2025-06-01
|
| Series: | Pharmacia |
| Online Access: | https://pharmacia.pensoft.net/article/149206/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849334703474081792 |
|---|---|
| author | Stanila Stoeva-Grigorova Maya Radeva-Ilieva Nadezhda Karkkeselyan Stela Dragomanova Gabriela Kehayova Simeonka Dimitrova Maria Petrova Snezha Zlateva Petko Marinov |
| author_facet | Stanila Stoeva-Grigorova Maya Radeva-Ilieva Nadezhda Karkkeselyan Stela Dragomanova Gabriela Kehayova Simeonka Dimitrova Maria Petrova Snezha Zlateva Petko Marinov |
| author_sort | Stanila Stoeva-Grigorova |
| collection | DOAJ |
| description | Fentanyl, a potent synthetic opioid, is widely used for severe pain management and anesthesia but poses significant risks due to its extreme potency and addictive potential. It acts primarily on μ-opioid receptors, with additional effects on κ- and δ-receptors, producing analgesia and adverse effects, such as respiratory depression, mediated via G-protein and β-arrestin signaling pathways. Fentanyl’s pharmacokinetics include rapid onset and a short duration, with extensive liver metabolism via CYP3A4 enzymes. Its high lipophilicity allows it to cross the blood-brain barrier quickly, contributing to its rapid central nervous system effects and associated risk of respiratory depression. Despite its therapeutic value, fentanyl’s potential to induce tolerance and dependence, coupled with escalating illicit use, underscores the need for enhanced prevention strategies, improved overdose management, and stricter regulatory measures to balance therapeutic utility with abuse prevention. |
| format | Article |
| id | doaj-art-822d57fa6e4d42c3ad1d0c75f61fe2d1 |
| institution | Kabale University |
| issn | 2603-557X |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Pensoft Publishers |
| record_format | Article |
| series | Pharmacia |
| spelling | doaj-art-822d57fa6e4d42c3ad1d0c75f61fe2d12025-08-20T03:45:30ZengPensoft PublishersPharmacia2603-557X2025-06-01721910.3897/pharmacia.72.e149206149206Historical perspectives and emerging trends in fentanyl use: Part 1 – Pharmacological profileStanila Stoeva-Grigorova0Maya Radeva-Ilieva1Nadezhda Karkkeselyan2Stela Dragomanova3Gabriela Kehayova4Simeonka Dimitrova5Maria Petrova6Snezha Zlateva7Petko Marinov8Medical UniversityMedical UniversityMedical UniversityMedical UniversityMedical UniversityMedical UniversityMedical UniversityMedical UniversityMedical UniversityFentanyl, a potent synthetic opioid, is widely used for severe pain management and anesthesia but poses significant risks due to its extreme potency and addictive potential. It acts primarily on μ-opioid receptors, with additional effects on κ- and δ-receptors, producing analgesia and adverse effects, such as respiratory depression, mediated via G-protein and β-arrestin signaling pathways. Fentanyl’s pharmacokinetics include rapid onset and a short duration, with extensive liver metabolism via CYP3A4 enzymes. Its high lipophilicity allows it to cross the blood-brain barrier quickly, contributing to its rapid central nervous system effects and associated risk of respiratory depression. Despite its therapeutic value, fentanyl’s potential to induce tolerance and dependence, coupled with escalating illicit use, underscores the need for enhanced prevention strategies, improved overdose management, and stricter regulatory measures to balance therapeutic utility with abuse prevention.https://pharmacia.pensoft.net/article/149206/download/pdf/ |
| spellingShingle | Stanila Stoeva-Grigorova Maya Radeva-Ilieva Nadezhda Karkkeselyan Stela Dragomanova Gabriela Kehayova Simeonka Dimitrova Maria Petrova Snezha Zlateva Petko Marinov Historical perspectives and emerging trends in fentanyl use: Part 1 – Pharmacological profile Pharmacia |
| title | Historical perspectives and emerging trends in fentanyl use: Part 1 – Pharmacological profile |
| title_full | Historical perspectives and emerging trends in fentanyl use: Part 1 – Pharmacological profile |
| title_fullStr | Historical perspectives and emerging trends in fentanyl use: Part 1 – Pharmacological profile |
| title_full_unstemmed | Historical perspectives and emerging trends in fentanyl use: Part 1 – Pharmacological profile |
| title_short | Historical perspectives and emerging trends in fentanyl use: Part 1 – Pharmacological profile |
| title_sort | historical perspectives and emerging trends in fentanyl use part 1 pharmacological profile |
| url | https://pharmacia.pensoft.net/article/149206/download/pdf/ |
| work_keys_str_mv | AT stanilastoevagrigorova historicalperspectivesandemergingtrendsinfentanylusepart1pharmacologicalprofile AT mayaradevailieva historicalperspectivesandemergingtrendsinfentanylusepart1pharmacologicalprofile AT nadezhdakarkkeselyan historicalperspectivesandemergingtrendsinfentanylusepart1pharmacologicalprofile AT steladragomanova historicalperspectivesandemergingtrendsinfentanylusepart1pharmacologicalprofile AT gabrielakehayova historicalperspectivesandemergingtrendsinfentanylusepart1pharmacologicalprofile AT simeonkadimitrova historicalperspectivesandemergingtrendsinfentanylusepart1pharmacologicalprofile AT mariapetrova historicalperspectivesandemergingtrendsinfentanylusepart1pharmacologicalprofile AT snezhazlateva historicalperspectivesandemergingtrendsinfentanylusepart1pharmacologicalprofile AT petkomarinov historicalperspectivesandemergingtrendsinfentanylusepart1pharmacologicalprofile |